We are happy to be recognized by leading scientific and business organizations
In Feb 2016, Zeto won a maximum award of $150,000 from the Epilepsy Foundation at its Shark Tank Event.
Winning this award was highly gratifying to us since the core audience was a mix of Neurologists, EEG technicians and hospital administrators.
In June 2017, Zeto won the Rosenman Innovator of the Year Award by QB3 a premier life science accelerator in Silicon Valley affiliated to UCSF, UCB and UCSC.
Zeto was recognized as one of the top 10 promising medical technology startups in the California Bay Area.
In Nov 2017, the American Diabetes Association held its 22nd Annual Leaders Forum HealthTech Showcase featuring start-up ventures in the life science and digital health arenas.
Zeto was selected as one of the top 3 companies from over 100 promising companies and presented to an audience of VCs, entrepreneurs and life science executives
In Dec 2017, Zeto won an investment of $200,000 from the Epilepsy Foundation as part of its New Therapy Commercialization Award Program.
We feel honored to have the Epilepsy Foundation on board as an investor. This investment is a testimonial to their belief and commitment to Zeto and we look forward to working with them in commercializing our product.Epilepsy Foundation NTCP Award page
After 700+ applications, 14 pitch events in 12 cities, and over 200 industry professionals weighing in, MedTech Innovator selected 2018’s 50 most transformative early-stage device, diagnostic and digital health companies.
Zeto is honored to be one of them. Zeto was featured at the WSGR medical device conference in June in San Francisco and will also be featured at The MedTech Conference, September 24-26, in PhiladelphiaPress Release Link